Journal: Molecular, Neurocognitive and Psychosis Risk Profiles in Youth and Young Adults With 22q11.2 Deletion Syndrome: Longitudinal Findings from a Multimodal Study
Product Description:
Genetic classification of neurodevelopmental disorders (NDDs) may help anticipate treatment tolerability; additional prescribing considerations may be needed for those with rare variants. Current psychotropic prescribing practices do not differ across rare genetic NDD subgroups.
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Professionals
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A